Portfolio News


Symform
 
Tigo Energy
 
Verdezyne
 
Viral Logic Systems Technology (VLST)
Portfolio Company News

The process used to identify targets also provides a clear path to developing biologic molecules that can be used for target validation studies. The VLST approach reduces the time to clinical development and improves the likelihood of clinical success. The company is headquartered in Seattle, Washington. Gerry Langeler is on the board.

 
<< Start < Prev 1 2 3 Next > End >>